Economic modeling and data analytics

Your market access discussions need to be supported by a robust economic rationale.


This may require a model to demonstrate the budget impact of your drug to payers, or a complex cost-effectiveness model designed to meet increasingly stringent evidence requirements of payers and health technology assessment agencies.


Whatever your need, our team have a wealth of experience in conceptualizing, developing, and adapting such models to fit the needs of different agencies. We can seamlessly supplement this with the appropriate data analytics you need to leverage data from completed studies in creative ways to feed into these models. All this is grounded in the insight and understanding of how those data will be viewed by payers.


Where there is more uncertainty, our systematic approach to disease modeling and forecasting future eligible patient populations can help you anticipate and plan for changing disease trajectories and evolving market landscapes.


Our consulting solutions include:

  • economic model conceptualization
  • cost-effectiveness modeling and validation
  • budget impact modeling
  • disease modeling
  • eligible patient population modeling and forecasting
  • trial-based analysis.


These services are provided by Avalere, PAI, PRMA Consulting, and Skysis – part of Fishawack Health.

Request a call

Your profound market access capabilities and extensive disease area knowledge has impressed us. We have enjoyed working with your team.

Associate Director, Market Access, top-5 pharmaceutical company

You have a vision; we are the consulting partner that will get you there.
We would be delighted to have a confidential conversation about your market access needs.